FI943931A0 - Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina - Google Patents

Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina

Info

Publication number
FI943931A0
FI943931A0 FI943931A FI943931A FI943931A0 FI 943931 A0 FI943931 A0 FI 943931A0 FI 943931 A FI943931 A FI 943931A FI 943931 A FI943931 A FI 943931A FI 943931 A0 FI943931 A0 FI 943931A0
Authority
FI
Finland
Prior art keywords
pct
5alpha
steroid
reductase inhibitors
indole derivatives
Prior art date
Application number
FI943931A
Other languages
English (en)
Swedish (sv)
Other versions
FI943931A (fi
Inventor
Graham Nigel Maw
Julian Blagg
Colin William Greengrass
Paul William Finn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943931A0 publication Critical patent/FI943931A0/fi
Publication of FI943931A publication Critical patent/FI943931A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
FI943931A 1992-02-28 1994-08-26 Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina FI943931A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204365A GB9204365D0 (en) 1992-02-28 1992-02-28 Indoles
PCT/EP1993/000380 WO1993017014A1 (en) 1992-02-28 1993-02-16 Indole derivatives as steroid 5 alpha-reductase inhibitors

Publications (2)

Publication Number Publication Date
FI943931A0 true FI943931A0 (fi) 1994-08-26
FI943931A FI943931A (fi) 1994-08-26

Family

ID=10711259

Family Applications (2)

Application Number Title Priority Date Filing Date
FI943931A FI943931A (fi) 1992-02-28 1994-08-26 Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
FI20001771A FI20001771A (fi) 1992-02-28 2000-08-09 Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiitoreina

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20001771A FI20001771A (fi) 1992-02-28 2000-08-09 Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiitoreina

Country Status (24)

Country Link
US (1) US5767139A (fi)
EP (1) EP0628040B1 (fi)
JP (1) JP2540016B2 (fi)
KR (1) KR950700287A (fi)
CN (1) CN1079465A (fi)
AT (1) ATE164376T1 (fi)
AU (1) AU3497793A (fi)
BR (1) BR9305991A (fi)
CA (1) CA2117610C (fi)
CZ (1) CZ207794A3 (fi)
DE (1) DE69317651T2 (fi)
DK (1) DK0628040T3 (fi)
ES (1) ES2115053T3 (fi)
FI (2) FI943931A (fi)
GB (1) GB9204365D0 (fi)
HR (1) HRP930227A2 (fi)
HU (1) HUT71126A (fi)
IL (1) IL104816A0 (fi)
MX (1) MX9301112A (fi)
NO (1) NO943187L (fi)
RU (1) RU94042391A (fi)
SK (1) SK100894A3 (fi)
WO (1) WO1993017014A1 (fi)
ZA (1) ZA931383B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
GB9403516D0 (en) * 1994-02-24 1994-04-13 Pfizer Ltd Indoles
GB9409583D0 (en) * 1994-05-13 1994-07-06 Pfizer Ltd Indoles
ATE219765T1 (de) * 1995-04-10 2002-07-15 Fujisawa Pharmaceutical Co Indolderivate als cgmp-pde inhibitoren
ES2263283T3 (es) 1998-08-03 2006-12-01 ELI LILLY & COMPANY Inhibidores de spla2 indol.
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2796279B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
US7795280B2 (en) * 2002-11-07 2010-09-14 N.V. Organon Indoles useful in the treatment of androgen-receptor related diseases
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557142A (en) * 1968-02-20 1971-01-19 Sterling Drug Inc 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
PH23498A (en) * 1984-08-06 1989-08-16 Sterling Drug Inc 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
ATE164376T1 (de) 1998-04-15
RU94042391A (ru) 1996-08-10
HU9402466D0 (en) 1994-10-28
NO943187L (no) 1994-09-13
CZ207794A3 (en) 1995-01-18
US5767139A (en) 1998-06-16
GB9204365D0 (en) 1992-04-08
CA2117610C (en) 2000-07-18
JP2540016B2 (ja) 1996-10-02
ZA931383B (en) 1994-08-26
JPH07500347A (ja) 1995-01-12
CA2117610A1 (en) 1993-09-02
EP0628040A1 (en) 1994-12-14
DE69317651D1 (en) 1998-04-30
SK100894A3 (en) 1995-04-12
FI943931A (fi) 1994-08-26
AU3497793A (en) 1993-09-13
NO943187D0 (no) 1994-08-29
DE69317651T2 (de) 1998-07-09
WO1993017014A1 (en) 1993-09-02
FI20001771A (fi) 2000-08-09
KR950700287A (ko) 1995-01-16
HRP930227A2 (en) 1996-10-31
MX9301112A (es) 1994-07-29
DK0628040T3 (da) 1998-04-27
HUT71126A (en) 1995-11-28
BR9305991A (pt) 1997-10-21
CN1079465A (zh) 1993-12-15
EP0628040B1 (en) 1998-03-25
ES2115053T3 (es) 1998-06-16
IL104816A0 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
FI952458A (fi) Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
DE69330601D1 (de) Serotoninergische ergolin derivate
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
AU3410693A (en) Carbamate derivatives and their use in medicine
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina

Legal Events

Date Code Title Description
MA Patent expired